Health Care & Life Sciences » Pharmaceuticals | Reliv International Inc.

Reliv International Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
68,206.70
57,345.00
51,768.90
45,512.80
41,788.80
36,115.70
Cost of Goods Sold (COGS) incl. D&A
39,151.40
32,470.80
29,766.50
26,374.50
24,312.90
21,685.30
Gross Income
29,055.30
24,874.20
22,002.40
19,138.40
17,475.80
14,430.40
SG&A Expense
27,553.10
24,778.50
23,276.80
19,675.30
17,659.20
16,294.90
EBIT
1,502.20
95.70
1,274.40
537.00
183.40
1,864.50
Unusual Expense
-
-
-
275.00
-
-
Non Operating Income/Expense
137.60
150.50
191.40
195.60
38.80
61.70
Interest Expense
82.50
100.10
113.90
106.70
109.30
95.60
Pretax Income
1,431.60
23.40
1,462.70
616.10
151.90
1,805.30
Income Tax
655.00
748.00
238.00
9.00
545.00
98
Consolidated Net Income
776.60
724.60
1,224.70
625.10
696.90
1,903.30
Net Income
776.60
724.60
1,224.70
625.10
696.90
1,903.30
Net Income After Extraordinaries
776.60
724.60
1,224.70
625.10
696.90
1,903.30
Net Income Available to Common
776.60
724.60
1,224.70
625.10
696.90
1,903.30
EPS (Basic)
0.42
0.40
0.70
0.34
0.38
1.03
Basic Shares Outstanding
1,802.70
1,809.40
1,838.60
1,845.00
1,845.00
1,845
EPS (Diluted)
0.42
0.40
0.67
0.34
0.38
1.03
Diluted Shares Outstanding
1,830.90
1,830.10
1,838.60
1,845.00
1,845.00
1,845
EBITDA
2,454.90
1,057.50
271.30
447.10
716.70
1,054.10
Non-Operating Interest Income
149.40
131.50
117.00
107.00
101.90
93.10

About Reliv International

View Profile
Address
136 Chesterfield Industrial Blvd
Chesterfield Missouri 63005
United States
Employees -
Website http://www.reliv.com
Updated 07/08/2019
Reliv' International, Inc. engages in the development, manufacture, and marketing of a proprietary line of nutritional supplements. It addresses basic nutrition, specific wellness, weight management, and sports nutrition. Its brand consists of Reliv Classic and Reliv NOW, Innergize!, FibRestore, and LunaRich X.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.